Skip to content
value.today

Aytu Bioscience vs Regenxbio Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Regenxbio Inc. is the larger company by market value: $513 M against $21 M for Aytu Bioscience, 25 times as much (market caps of Oct 26, 2026 for Aytu Bioscience and Oct 6, 2026 for Regenxbio Inc.).
  • Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $58 M for Aytu Bioscience in the year to June 2026.
  • Both made a net loss: $14 M for Aytu Bioscience and $194 M for Regenxbio Inc.
  • Aytu Bioscience keeps more of each dollar of sales: a net margin of -24.8% against -113.8% for Regenxbio Inc.
  • Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -13.3% for Aytu Bioscience.
  • Both are in the distress zone of the Altman Z-score.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

01172343514682020202120222023202420252026Aytu Bioscience 94Regenxbio Inc. 35

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$0B$0B2017201820192020202120222023202420252026Aytu Bioscience $0BRegenxbio Inc. $0B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAytu Bioscience
AYTU · #24,231 in the world
Regenxbio Inc.
RGNX · #12,415 in the world
Profile
Country🇺🇸 USA🇺🇸 USA
SectorHealthcareHealthcare
IndustryBiotechnologyBiotechnology
Founded——
Size
Market cap$21 M$513 M
Revenue$58 M$170 M
Net income$-14 M▲ best$-194 M
Employees—372
Valuation
Price to sales0.3×3.3×
Price to book0.6×5.0×
Free cash flow yield15.7%▲ best-24.6%
Profitability
Gross margin64.0%—
Operating margin-14.4%▲ best-94.6%
Net margin-24.8%▲ best-113.8%
Return on equity-52.5%▲ best-107.0%
Growth
Revenue growth-13.3%104.5%▲ best
Revenue growth, 3 years a year-18.8%14.8%▲ best
Financial strength
Debt to equity0.3×—
Interest cover-4.4×—
Cash
Free cash flow margin5.7%▲ best-74.1%
Strength scores
Piotroski F-score4 of 9—
Altman Z-score zonedistressdistress
Data as ofMarket cap Oct 2026; ratios FY2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, Aytu Bioscience or Regenxbio Inc.?

Regenxbio Inc. is the larger company by market value: $513 M against $21 M for Aytu Bioscience, 25 times as much (market caps of Oct 26, 2026 for Aytu Bioscience and Oct 6, 2026 for Regenxbio Inc.).

Which makes more money, Aytu Bioscience or Regenxbio Inc.?

Regenxbio Inc. had more revenue: $170 M in the year to December 2025 against $58 M for Aytu Bioscience in the year to June 2026. Both made a net loss: $14 M for Aytu Bioscience and $194 M for Regenxbio Inc.

Which is more profitable, Aytu Bioscience or Regenxbio Inc.?

Aytu Bioscience keeps more of each dollar of sales: a net margin of -24.8% against -113.8% for Regenxbio Inc.

Which is growing faster, Aytu Bioscience or Regenxbio Inc.?

Regenxbio Inc.'s revenue grew faster in its latest fiscal year: +104.5% against -13.3% for Aytu Bioscience.

Which is financially stronger, Aytu Bioscience or Regenxbio Inc.?

Both are in the distress zone of the Altman Z-score.